|
| Home : Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China |
|
Jun 19
2020 |
Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China |
|
SUZHOU, China, June 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/innovent-announces-the-nmpa-granted-marketing-approval-for-byvasda-bevacizumab-biosimilar-in-china-301080076.html |
| |
|
Related News
|
» Radiko Announces Management Cease Trade Order
» X Financial to Report First Quarter 2020 Financial Results on June 30, 2020
|
|
|
